MedPath

ADR-001-N2

Not Applicable
Conditions
Compensated liver cirrhosis (Child-Pugh A)
Registration Number
JPRN-jRCT2033220602
Lead Sponsor
Terai Shuji
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
9
Inclusion Criteria

1)Patients who received at least one dose of ADR-001 in the ADR-001-N1 Study.
2)Patients capable of giving written informed consent.

Exclusion Criteria

1)Patients decided to be ineligible for this study by the investigator.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The amount of change in Albumin-bilirubin (ALBI) score
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath